1. Alzheimer's disease: how to give and monitor tacrine therapy
- Author
-
Woo, James K. and Lantz, Melinda S.
- Subjects
Alzheimer's disease -- Drug therapy ,Health ,Seniors - Abstract
The case of a 91-year-old woman is used to discuss the administration of tacrine therapy for enhancing cognitive functions in patients with Alzheimer's disease. Tacrine, an inhibitor of acetylcholinesterase, is generally given to patients with no history of liver disease. Patients who receive the drug, which causes increased liver transaminases and gastrointestinal effects, usually require a follow-up cognitive test and weekly blood tests to assess liver function., Mrs. L, age 91, has resided in a nursing home since she was diagnosed with Alzheimer's disease 7 years ago. Based on her medical history and the results of mental [...]
- Published
- 1995